Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P 500 volatile in choppy trading; Mideast deal, SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
November 5, 2015 7:12 AM ESTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $19.00 (from $18.00), following the company's 1Q16 earnings report. Revenue was $43.9M (up 11% Y/Y after accounting for the end of the Asahi distribution agreement) vs. guidance of $43.9M and EPS was... More
Cardiovascular Systems (CSII) Tops Q1 EPS by 1c
November 4, 2015 4:25 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q1 EPS of ($0.41), $0.01 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $43.9 million versus the consensus estimate of $43.9 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More